12/17/2014 - 4:49pm

The Food and Drug Administration on Wednesday approved Xtoro (finafloxacin otic suspension), a new drug that's used to treat acute otitis externa, commonly known as swimmer's ear. 

12/16/2014 - 12:26pm

 Greenstone announced the launch of celecoxib — the authorized generic version of Pfizer's Celebrex — to its line of generic pharmaceuticals. 

12/16/2014 - 11:27am

Novartis on Tuesday received approval from the Food and Drug Administration for Signifor long-acting release (pasireotide) for injectable suspension, for intramuscular use. 

 

12/16/2014 - 11:14am

Dr. Reddy's Labs announced the launch of valganciclovir tablets USP in 450-mg strength. 

 

12/11/2014 - 3:24pm

Teva Pharmaceuticals on Thursday announced the availability of levalbuterol inhalation solution, USP (concentrate), a generic equivalent to Xopenex inhalation solution concentrate. 

12/11/2014 - 3:15pm

Lupin Pharmaceuticals launched the authorized generic version of Celebrex capsules in 50-, 100-, 200- and 400-mg dosage strengths. 

12/11/2014 - 1:21pm

Mylan on Thursday announced the launch of methocarbamol injection USP, 100 mg. 

12/11/2014 - 1:14pm

Mylan on Thursday announced the launch of prednisolone sodium phosphate orally disintegrating tablets in 10-mg, 15-mg and 30-mg dosage strengths. 

 

12/11/2014 - 11:44am

The Food and Drug Administration on Wednesday approved Gardasil 9 for the prevention of certain diseases caused by nine types of human papillomavirus.